Ninds BPN dmpk consulting - jiunn LIN

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201700006C
Awardee
Awarding agency
Obligated
$375,790

Award facts

Opportunity
Contract value 100% obligated
  • $375,790.00 Current, with exercised options
  • $377,290.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
Total Small Business
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00015 · Drug manufacturing pharmacokinetics (dmpk) consulting services -$5,190
Other Administrative Action P00014 · Drug metabolism and pharmacokinetics consulting services $0
Exercise an Option P00013 · Exercise optional quantity MOD for funding 30 hours of consulting. $7,230
Funding Only Action P00012 · Drug metabolism and pharmacokinetics consulting services -$4,295
Exercise an Option P00011 $36,150
Exercise an Option P00010 · Add supplemental funding to option 4 - heal funding $3,615
Supplemental Agreement for work within scope P00009 · Add supplemental funding to option 3 - consulting support services - jiunn LIN $17,550
Exercise an Option P00008 · Exercise option 4 and add supplemental funding to option 3 - consulting support services - jiunn LIN $77,100
Exercise an Option P00007 · Exercise option 3 and add supplemental funding - consulting support services - jiunn LIN $46,200
Exercise an Option P00006 $22,800
Exercise an Option P00005 $33,850
Supplemental Agreement for work within scope P00004 $17,680
Exercise an Option 3 $44,200
Exercise an Option 2 $12,900
Exercise an Option 1 $21,500
Original award $44,500
Show all 16

About this award

The National Institute of Neurological Disorders and Stroke awarded a definitive contract to Lin Jiunn for drug manufacturing pharmacokinetics (DMPK) consulting support services on January 25, 2017, under a total small business set-aside, with a ceiling value of $377,290.

Place of performance is Bethesda, MD. The contract was structured as firm fixed price and reached ultimate completion on June 7, 2022. The originating work supports NINDS's biomedical research initiatives through expert consulting in drug metabolism and pharmacokinetics.

Quick answers

Who was awarded contract HHSN271201700006C?

HHSN271201700006C was awarded to Lin Jiunn by National Institute on Drug Abuse (National Institutes of Health) on January 25, 2017.

How much is contract HHSN271201700006C worth?

The government has obligated $375,790 on HHSN271201700006C. Its potential value, with all options, is $377,290.

Which agency awarded contract HHSN271201700006C?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700006C, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Was contract HHSN271201700006C competed?

The extent of competition for HHSN271201700006C was competed under sap. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award